Cargando…

Potential role for mucosally active vaccines against pneumococcal pneumonia

Pneumococcal pneumonia is a life-threatening disease with high mortality and morbidity among children under 5 years of age, the elderly and immunocompromised individuals worldwide. Protection against pneumococcal pneumonia relies on successful regulation of colonisation in the nasopharynx and a bris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jambo, Kondwani C., Sepako, Enoch, Heyderman, Robert S., Gordon, Stephen B.
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Trends Journals 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855428/ https://www.ncbi.nlm.nih.gov/pubmed/20031415 http://dx.doi.org/10.1016/j.tim.2009.12.001

Ejemplares similares

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
por: Kalata, Newton L., et al.
Publicado: (2019)

Incomplete Recovery of Pneumococcal CD4 T Cell Immunity after Initiation of Antiretroviral Therapy in HIV-Infected Malawian Adults
por: Sepako, Enoch, et al.
Publicado: (2014)

Naturally-Acquired Influenza-Specific CD4(+) T-Cell Proliferative Responses Are Impaired in HIV-Infected African Adults
por: Jambo, Kondwani C., et al.
Publicado: (2012)

Impaired CD4 T Cell Memory Response to Streptococcus pneumoniae Precedes CD4 T Cell Depletion in HIV-Infected Malawian Adults
por: Glennie, Sarah J., et al.
Publicado: (2011)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
por: Gordon, Stephen B., et al.
Publicado: (2008)

Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)

The influence of pneumococcal conjugate vaccine-13 on nasal colonisation in a controlled human infection model of pneumococcal carriage in Malawi: a double-blinded randomised controlled trial protocol
por: Morton, Ben, et al.
Publicado: (2022)

Influenza-like illness is associated with high pneumococcal carriage density in Malawian children
por: Nyazika, Tinashe K., et al.
Publicado: (2020)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
por: Chiu, Fang-Feng, et al.
Publicado: (2023)

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study
por: Thindwa, Deus, et al.
Publicado: (2023)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
por: Shen, Ching-Fen, et al.
Publicado: (2020)

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults
por: Peno, Chikondi, et al.
Publicado: (2018)

Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung
por: Wright, Adam K. A., et al.
Publicado: (2013)

A pneumococcal controlled human infection model in Malawi: Transfer of an established pneumococcal carriage model from Liverpool, UK to Blantyre, Malawi – A feasibility study
por: Morton, Ben, et al.
Publicado: (2020)

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation
por: Wolf, Asia-Sophia, et al.
Publicado: (2022)

Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine
por: Carniel, Beatriz F., et al.
Publicado: (2021)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
por: Swarthout, Todd D., et al.
Publicado: (2020)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
por: Orami, Tilda, et al.
Publicado: (2020)

AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid
por: Jambo, Kondwani C, et al.
Publicado: (2007)

Pneumonia in Infancy and Risk for Asthma: The Role of Familial Confounding and Pneumococcal Vaccination
por: Rhedin, Samuel, et al.
Publicado: (2021)

13. The Efficacy and Effectiveness of Pneumococcal Vaccines against Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis
por: Childs, Lana, et al.
Publicado: (2021)

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization
por: Jochems, Simon P., et al.
Publicado: (2019)

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization
por: Jochems, Simon P., et al.
Publicado: (2022)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
por: Webster, Julia, et al.
Publicado: (2011)

Pneumococcal vaccination and childhood pneumonia in South Africa
por: Mulholland, Kim, et al.
Publicado: (2015)

Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study
por: Iroh Tam, Pui-Ying, et al.
Publicado: (2022)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study
por: Chan, Jocelyn, et al.
Publicado: (2021)

Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice
por: Choi, Sang-Yoon, et al.
Publicado: (2013)

Pneumococcal pneumonia
por: Goldblatt, David, et al.
Publicado: (2020)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study
por: Lawrence, Hannah, et al.
Publicado: (2020)

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study
por: Dula, Dingase, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tu6aoecjc9fh7e0eqm43it3hjk